Christian is a seasoned Market Access professional with over 20 years of experience in the International Biotech and Pharmaceutical industry. He has been involved in over 50 HTAs across Europe and has built up a strong network of key influencers including EU and national agencies. Prior to co-founding MAP in 2012, he led market access teams and submissions at InterMune, Gilead, Pfizer and Genzyme on a very broad range of products and disease areas from chronic disease to ultra-orphan indications.

Christian is a member of the Board of EUCOPE (European Confederation of Pharmaceutical Entrepreneurs); he is also a member of the Steering Group of EMIG (Ethical Medicines Industry Group) in the UK and Ireland.

Angelika began her legal journey in Poland where she obtained a Master's Degree in Law and gained experience in international corporate and commercial law. Having developed an interest in the common law system, Angelika has recently graduated from BPP University with a Distinction in Graduate Diploma in Law. She actively supports MAP clients and members by conducting legal research, as well as leading the development of MAP Online Legal section with insights in the areas of marketing authorisation, intellectual property, data protection, Brexit and EU competition law. She also has expertise in the ABPI Code of Practice and regularly participates in conferences and meeting groups where she helps realise MAP’s vision to accelerate patient access to medicines, medical devices and diagnostics.

Aryan graduated with a BSc (Hons) in Business Management with a majoring in management consultancy at the Lancaster University Management School. Prior to his career in biopharmaceuticals, Aryan spent two years working in logistics consultancy in Doha, Qatar specialising in healthcare and medical devices. Aryan has also worked in business development roles across tech and maritime sectors in the UK and in the Netherlands. Prior to joining MAP, Aryan worked at a contract research organisation as a pricing and proposals manager working closely with biopharmaceutical clients. He is currently studying an MSc in Health Economics and Policy at the University of Birmingham which made a career in market access and HEOR a natural career move.